Professional Marketing briefs

Share this article:
Romark Laboratories received a warning letter from the FDA regarding its product Alinia (nitazoxanide). The FDA charged that the sales aid and oral statements for Alinia are false or misleading because they promote unapproved uses and broaden the indication for Alinia, make unsubstantiated superiority claims, omit and minimize the risks associated with Alinia and/or make misleading compliance claims.

Roche added a new component to its $14 million diabetes education campaign, which pairs healthcare practitioners with Roche staff. “Creative Coaching” helps healthcare professionals with “the art of patient engagement.” Roche manufactures the Accu-Chek line of blood glucose monitors. The professional education program, Behavior Change through Patient Engagement, is multifaceted and includes a website with online tools and information.

San Mateo, CA-based Epocrates unveiled an OTC drug module that will allow clinicians to access the latest information for hundreds of brand name OTC drugs right from their iPhone, BlackBerry, Palm or Windows device. The OTC drug module is already used by more than 625,000 in the US.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...